March 2026
The global bispecific antibodies CDMO market expands with demand for next-generation therapeutics, advanced expression systems, and regulatory compliance expertise.
December 2025
The global bispecific antibodies market size is valued at USD 12.47 billion in 2025 and is expected to attain around USD 484.88 billion by 2034 at a CAGR of 44.2%.
May 2026
Europe Pharmaceutical CDMO market size is projected to hit around USD 94.94 billion by 2035, rising from USD 45.68 billion in 2025, growing at a CAGR of 7.59%.
May 2026
The global active pharmaceutical ingredients CDMO market size is evaluated at USD 116.77 billion in 2025 and is predicted to hit around USD 231.48 billion by 2035, growing at a CAGR of 7.81%.
April 2026
The global chemical drug CDMO market size was evaluated at USD 13.20 billion in 2025 and is predicted to hit around USD 29.84 billion by 2035, growing at a CAGR of 8.50%.
April 2026
The global chemical API CDMO market size was evaluated at USD 16.80 billion in 2025 and is predicted to hit around USD 40.88 billion by 2035, growing at a CAGR of 9.30%.
April 2026
The global cancer monoclonal antibodies market size reached USD 125.10 billion in 2025 and is predicted to hit around USD 658.07 billion by 2035, with a solid CAGR of 18.06%.
April 2026
The global mRNA therapeutics CDMO market size is estimated to hit around USD 14.63 billion by 2035 from USD 5.09 billion in 2025, with a CAGR of 11.14%.
March 2026
The global live biotherapeutic products and microbiome CDMO market size is estimated to hit around USD 1,838.56 million by 2035 from USD 76.77 million in 2025, at a CAGR of 37.38%.
March 2026
The hormonal drug CDMO market is expanding with rising demand for outsourced development and manufacturing of therapies for endocrine and reproductive health.
March 2026
The global veterinary monoclonal antibodies market size is estimated to hit around USD 5.62 billion by 2035 increasing from USD 1.74 billion in 2025, with a CAGR of 12.44%.
March 2026
The global pharmaceutical CDMO market size is calculated at USD 197.40 billion in 2025 and is projected to hit around USD 392.67 billion by 2035 with a CAGR of 7.12%.
February 2026
The global biologics CDMO market size was valued at USD 23.08 billion in 2025 and is projected to hit around USD 55.11 billion by 2035 with a healthy CAGR of 9.14%.
February 2026
The global veterinary CRO and CDMO market size was valued at USD 7.73 billion in 2025 and is predicted to surpass around USD 17.15 billion by 2035 with a CAGR of 8.30%.
February 2026
The global research antibodies market size accounted for USD 4.64 billion in 2025 and is projected to hit around USD 7.56 billion by 2035 with a CAGR of 5%.
January 2026
The global bispecific antibody therapeutics contract manufacturing market size was evaluated at USD 9.82 billion in 2025 and is predicted to hit around USD 218.92 billion by 2035, growing at a CAGR of 36.4%.
January 2026
The global investigational new drug CDMO market size is estimated to hit around USD 10.90 billion by 2035 from USD 5.61 billion in 2025, with a CAGR of 6.87%.
January 2026
The global plug-and-play CDMO market is growing rapidly as pharma and biotech firms seek flexible, scalable, and fast-track manufacturing solutions.
January 2026
The global next-generation bispecific antibody market size was evaluated at USD 9.53 billion in 2025 and is predicted to hit around USD 52.08 billion by 2035, growing at a CAGR of 18.51%.
January 2026
The global monoclonal antibodies market size is evaluated at USD 286.32 billion in 2025 and is projected to hit around USD 880.01 billion by 2035, with a CAGR of 11.88%.
January 2026
The global radiopharmaceutical CDMO market size was evaluated at USD 3.24 billion in 2025 and is predicted to hit around USD 8.50 billion by 2035, growing at a CAGR of 10.12%.
December 2025
The polyclonal antibodies market size was estimated at USD 1.70 billion in 2025 and is expected to hit around USD 2.95 billion by 2035 with a CAGR of 5.77%.
November 2025
The global small molecule innovator CDMO market size is valued at USD 56.41 billion in 2025 and is projected to hit around USD 97.67 billion by 2034 with a CAGR of 6.29%.
October 2025
The global oral solid dose oncology CDMO market is growing with rising demand for outsourced cancer drug manufacturing and advanced solid dosage formulation.
October 2025
The global exosome-based cancer therapy CDMO market is growing as demand rises for scalable manufacturing and delivery solutions in exosome therapeutics.
October 2025
The global checkpoint inhibitor biologics CDMO market is growing as demand rises for outsourced biologics development and scalable immuno-oncology manufacturing.
September 2025
The global AI-integrated CDMO process optimization market is growing as contract manufacturers adopt AI to streamline drug development and manufacturing workflows.
September 2025
The global peptide therapeutics CDMO market is growing as pharma and biotech companies outsource complex peptide drug development and manufacturing.
September 2025
The global LNP CDMO market size was evaluated at USD 205.47 million in 2024 and is predicted to hit around USD 820.46 million by 2034, growing at a CAGR of 14.85%.
September 2025
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com